Skip to main content
Kent Academic Repository

Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies

Ferrara, Francesca, Del Rosario, Joanne Marie M., da Costa, Kelly A. S., Kinsley, Rebecca, Scott, Simon D., Fereidouni, Sasan, Thompson, Craig P., Kellam, Paul, Gilbert, Sarah C., Carnell, George, and others. (2021) Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies. Frontiers in Immunology, 12 . ISSN 1664-3224. (doi:10.3389/fimmu.2021.661379) (KAR id:88691)

Abstract

Influenza B viruses (IBV) cause respiratory disease epidemics in humans and are therefore components of seasonal influenza vaccines. Serological methods are employed to evaluate vaccine immunogenicity prior to licensure. However, classical methods to assess influenza vaccine immunogenicity such as the hemagglutination inhibition assay (HI) and the serial radial hemolysis assay (SRH), have been proven to have many limitations. As such, there is a need to develop innovative methods that can improve on these traditional assays and provide advantages such as ease of production and access, safety, reproducibility, and specificity. It has been previously demonstrated that the use of replication-defective viruses, such as lentiviral vectors pseudotyped with influenza A hemagglutinins in microneutralization assays (pMN) is a safe and sensitive alternative to study antibody responses elicited by natural influenza infection or vaccination. Consequently, we have produced Influenza B hemagglutinin-pseudotypes (IBV PV) using plasmid-directed transfection. To activate influenza B hemagglutinin, we have explored the use of proteases in increasing PV titers via their co-transfection during pseudotype virus production. When tested for their ability to transduce target cells, the influenza B pseudotypes produced exhibit tropism for different cell lines. The pseudotypes were evaluated as alternatives to live virus in microneutralization assays using reference sera standards, mouse and human sera collected during vaccine immunogenicity studies, surveillance sera from seals, and monoclonal antibodies (mAbs) against IBV. The influenza B pseudotype pMN was found to effectively detect neutralizing and cross-reactive responses in all assays and shows promise as an effective and versatile tool in influenza research.

Item Type: Article
DOI/Identification number: 10.3389/fimmu.2021.661379
Subjects: Q Science > QR Microbiology > QR355 Virology
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Nigel Temperton
Date Deposited: 15 Jun 2021 14:25 UTC
Last Modified: 09 Sep 2022 08:17 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/88691 (The current URI for this page, for reference purposes)

University of Kent Author Information

Ferrara, Francesca.

Creator's ORCID:
CReDIT Contributor Roles:

Kinsley, Rebecca.

Creator's ORCID:
CReDIT Contributor Roles:

Scott, Simon D..

Creator's ORCID: https://orcid.org/0000-0002-8290-0461
CReDIT Contributor Roles:

Temperton, Nigel J..

Creator's ORCID: https://orcid.org/0000-0002-7978-3815
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.